僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Codrituzumab is a monoclonal antibody targeting GPC3 （glypican-3）. GPC3 is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma （HCC）. Codrituzumab induces antibody-dependent cellular cytotoxicity （ADCC） and inhibits tumor growth